Epstein-Barr Virus-associated Post-Transplant Lymphoproliferative Disorders presented as Interstitial Pneumonia; Successful Recovery with Rituximab

被引：14
|
作者：
Kunitomi, Akane [1 ]
Arima, Nobuyoshi [1 ]
Ishikawa, Takayuki [2 ]
机构：
[1] Kitano Hosp, Tazuke Kofukai Med Res Inst 1, Dept Hematol, Osaka, Japan
[2] Kyoto Univ, Dept Hematol & Oncol, Grad Sch Med, Kyoto, Japan
来源：
HAEMATOLOGICA | 2007年 / 92卷 / 04期
关键词：
EBV; PTLD; rituximab; interstitial pneumonia;
D O I：
10.3324/haematol.11142
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We describe a patient that developed Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorders (PTLD), which presented as interstitial pneumonia. He had received allogeneic bone marrow transplantation for the treatment of acute myeloid leukemia 17 months before, when he developed hypoxemia requiring emergent admission. Chest computed tomography revealed pulmonary interstitial shadows, but neither hepatomegaly nor lymphadenopathy were detected. Bronchoscopy with lung biopsy revealed a lymphomatous proliferation of EBV-infected B cells. The interstitial pneumonia rapidly deteriorated, but improved dramatically after treatment with anti-CD20 monoclonal antibody (rituximab). This is the first report of a patient with lung EBV-PTLD that presented as interstitial pneumonia and was successfully treated with rituximab.
引用
收藏
页码：49 / 52
页数：4
相关论文
共 50 条
  • [41] CD20-negative Epstein-Barr virus-associated post-transplant lymphoproliferative disease refractory to rituximab in a patient with severe aplastic anemia
    Muramatsu, Hideki
    Takahashi, Yoshiyuki
    Shimoyama, Yoshie
    Doisaki, Sayoko
    Nishio, Nobuhiro
    Ito, Yoshinori
    Hama, Asahito
    Shimada, Akira
    Yagasaki, Hiroshi
    Ito, Masafumi
    Kojima, Seiji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (06) : 779 - 781
  • [42] Genomic diversity of Epstein-Barr Virus in post-transplant lymphoproliferative disorder
    Martinez, Olivia
    Maloney, Eden
    Busque, Vincent
    Hui, Sin Ting
    Esquivel, Carlos O.
    Krams, Sheri
    PEDIATRIC TRANSPLANTATION, 2019, 23
  • [43] Epstein-Barr Virus Genome Variation in Post-Transplant Lymphoproliferative Disorder
    Maloney, Eden
    Busque, Vincent A.
    Hui, Sin Ting
    Krams, Sheri M.
    Esquivel, Carlos O.
    Martinez, Olivia M.
    TRANSPLANTATION, 2018, 102 : S95 - S95
  • [44] Genomic Diversity of Epstein-Barr Virus in Post-Transplant Lymphoproliferative Disorder
    Maloney, E.
    Martinez, O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 402 - 402
  • [45] Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease
    Savoldo, B
    Rooney, CM
    Quiros- Tejeira, RE
    Caldwell, Y
    Wagner, HJ
    Lee, T
    Finegold, MJ
    Dotti, G
    Heslop, HE
    Goss, JA
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (03) : 566 - 572
  • [46] Chorioretinal post-transplant lymphoproliferative disorder induced by the Epstein-Barr virus
    Demols, PF
    Cochaux, PM
    Velu, T
    Caspers-Velu, L
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2001, 85 (01) : 93 - 95
  • [47] Rituximab for the treatment of Epstein-Barr virus associated lymphoproliferative disorders.
    George, D
    Small, TN
    Boulad, F
    Castro-Malaspina, H
    Childs, BH
    Jakubowski, A
    Kernan, NA
    Papadopoulos, EB
    Prasad, V
    Young, JW
    Barnett, L
    O'Reilly, RJ
    BLOOD, 2000, 96 (11) : 405A - 405A
  • [48] Risk Factors for Post-Transplant Lymphoproliferative Disorders in Epstein-Barr Virus Mismatch Lung Transplant Recipients
    Courtwright, A.
    Burkett, P.
    Camp, P.
    Divo, M.
    El-Chemaly, S.
    Keller, S.
    Mody, G.
    Rosas, I.
    Singh, S.
    Goldberg, H.
    Mallidi, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 263 - 263
  • [49] Post-transplant lymphoproliferative disorders and its relationship with Epstein Barr Virus
    Franco, A
    Jiménez, L
    Aranda, I
    Alvarez, L
    González, M
    Rocamora, N
    Olivares, J
    NEFROLOGIA, 2002, 22 (05): : 463 - 469
  • [50] Idiopathic Pulmonary Fibrosis Lung Transplant Recipients are at Increased Risk for Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorder
    Iasella, C. J.
    Winters, S.
    Kois, A.
    Cho, J.
    Hannan, S. J.
    Koshy, R.
    Moore, C.
    Lendermon, E. A.
    Pilewski, J.
    Morrell, M.
    Sanchez, P. G.
    Kass, D.
    Alder, J. K.
    Nouriea, S. M.
    McDyer, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S382 - S383
12345